Society for Endocrinology - a world-leading authority on hormones

Amylin's long-delayed diabetes drug gets US nod (Associated Press, 28 January 2012)

01 Feb 2012


The US Food and Drug Administration has approved the long-acting GLP-1 agonist Bydureon for the treatment of type 2 diabetes mellitus.

Full article